# OnCo record nct05126719 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05126719/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05126719", "NCT05126719" ;
  schema:name "A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent Metastatic Nasopharyngeal Carcinoma"@en ;
  schema:description "A phase 2 trial of MRG003, Capecitabine, Docetaxel in nasopharyngeal carcinoma, run by Lepu Biopharma Co., Ltd., active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05126719/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05126719> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2023-04-06" ;
  onco:cancers <https://onco.cc/cancers/nasopharyngeal/>, <https://onco.cc/cancers/recurrent-metastatic-nasopharyngeal-carcinoma/> ;
  onco:drugs <https://onco.cc/drugs/mrg003/>, <https://onco.cc/drugs/capecitabine/>, <https://onco.cc/drugs/docetaxel/> ;
  onco:companies <https://onco.cc/companies/lepu-biopharma/> .